Performance of two questionnaires to measure treatment adherence in patients with Type-2 Diabetes

被引:20
|
作者
Prado-Aguilar, Carlos A. [1 ,4 ]
Martinez, Yolanda V. [1 ]
Segovia-Bernal, Yolanda [2 ]
Reyes-Martinez, Rosendo [3 ]
Arias-Ulloa, Raul [4 ]
机构
[1] Inst Mexicano Seguro Social, Unidad Invest Epidemiol & Serv Salud, Hosp Gen Zona 1, Aguascalientes, Ags, Mexico
[2] Inst Mexicano Seguro Social, Unidad Med Ambulatoria, Aguascalientes, Ags, Mexico
[3] Inst Mexicano Seguro Social, Unidad Med Familiar, Aguascalientes, Ags, Mexico
[4] Univ Autonoma Aguascalientes, Depto Salud Publ, Aguascalientes, Ags, Mexico
来源
BMC PUBLIC HEALTH | 2009年 / 9卷
关键词
MEDICATION ADHERENCE; THERAPY;
D O I
10.1186/1471-2458-9-38
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Most valid methods to measure treatment adherence require time and resources, and they are not easily applied in highly demanding Primary Health Care Clinics (PHCC). The objective of this study was to determine sensitivity, specificity, predictive values, likelihood ratios, and post-test probabilities of two novel questionnaires as proxy measurements of treatment adherence in Type-2 diabetic patients. Methods: Two questionnaires were developed by a group of experts to identify the patient's medical prescription knowledge (knowledge) and their attitudes toward treatment adherence (attitudes) as proxy measurements of adherence. The questionnaires were completed by patients receiving care in PHCC pertaining to the Mexican Institute of Social Security in Aguascalientes (Mexico). Pill count was used as gold standard. Participants were selected randomly, and their oral hypoglycemic prescriptions were studied. The main outcome measures for each questionnaire were sensitivity, specificity, predictive values, likelihood ratios, and post-test probabilities, all as an independent questionnaire test and in a serial analysis. Results: Adherence prevalence was 27.0% using pill count. Knowledge questionnaire showed the highest sensitivity (68.1%) and negative predictive value (82.2%), the lowest negative likelihood ratio (0.58) and post-test probability for a negative result (0.16). Serial analysis showed the highest specificity (77.4%) and positive predictive value (40.1%) as well as the highest positive likelihood ratio (1.8) and post-test probability for a positive result (0.39). Conclusion: Medical Prescription Knowledge questionnaire showed the best performance as proxy measurement to identify non-adherence in type 2 diabetic patients regarding negative predictive value, negative likelihood ratio, and post-test probability for a negative result. However, Medical Prescription Knowledge questionnaire performance may change in contexts with higher adherence prevalence. Therefore, more research is needed before using this method in other contexts.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Performance of two questionnaires to measure treatment adherence in patients with Type-2 Diabetes
    Carlos A Prado-Aguilar
    Yolanda V Martínez
    Yolanda Segovia-Bernal
    Rosendo Reyes-Martínez
    Raul Arias-Ulloa
    BMC Public Health, 9
  • [2] Adherence of Type-2 Diabetic Patients to Treatment
    Al-Majed, Hana T.
    Ismael, Ali E.
    Al-Khatlan, Haya M.
    El-Shazly, Medhat K.
    KUWAIT MEDICAL JOURNAL, 2014, 46 (03): : 225 - 232
  • [3] Treatment for Patients with Type-2 Diabetes
    Landgraf, Ruediger
    Kellerer, Monika
    Aberle, Jens
    Fach, Eva-Maria
    Gallwitz, Baptist
    Hamann, Andreas
    Joost, Hans-Georg
    Klein, Harald
    Mueller-Wieland, Dirk
    Nauck, Michael A.
    Reuter, Hans-Martin
    Schreiber, Stephan
    Siegel, Erhard
    DIABETOLOGE, 2019, 15 (02): : 146 - 167
  • [4] Treatment for Patients with Type-2 Diabetes
    Landgraf, Rueediger
    Aberle, Jens
    Birkenfeld, Andreas L.
    Gallwitz, Baptist
    Kellerer, Monika
    Klein, Harald H.
    Mueller-Wieland, Dirk
    Nauck, Michael A.
    Wiesner, Tobias
    Siegel, Erhard
    DIABETOLOGIE UND STOFFWECHSEL, 2021, 16 : S168 - S206
  • [5] NEUROPSYCHOLOGICAL COGNITIVE PERFORMANCE OF PATIENTS WITH TYPE-2 DIABETES
    MATTLAR, CE
    FALCK, B
    RONNEMAA, T
    HYYPPA, MT
    SCANDINAVIAN JOURNAL OF REHABILITATION MEDICINE, 1985, 17 (02): : 101 - 105
  • [6] Treatment of hypertension in patients with type-2 diabetes mellitus
    Kjeldsen, SE
    Os, I
    Farsang, C
    Mallion, JM
    Hansson, L
    Sleight, P
    JOURNAL OF HYPERTENSION, 2000, 18 (09) : 1345 - 1346
  • [7] Treatment of hypertension in patients with type-2 diabetes mellitus
    Kjeldsen, SE
    Os, I
    Farsang, C
    Mallion, JM
    Hansson, L
    Sleight, P
    BLOOD PRESSURE, 2000, 9 (06) : 363 - 364
  • [8] Concordance between two methods in measuring treatment adherence in patients with type 2 diabetes
    Lopez-Simarro, Flora
    Brotons, Carlos
    Moral, Irene
    Aguado-Jodar, Alba
    Cols-Sagarra, Celia
    Miravet-Jimenez, Sonia
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 743 - 750
  • [9] Adherence questionnaires to oral antidiabetic treatment in patients with Diabetes Mellitus 2: systematic review
    Esquivel-Prados, Elisabet
    Pareja-Martinez, Elisa
    Garcia-Corpas, Jose P.
    ARS PHARMACEUTICA, 2023, 64 (02) : 173 - 186
  • [10] Barriers of medication adherence in patients with type-2 diabetes: a pilot qualitative study
    Rezaei, Mehdi
    Valiee, Sina
    Tahan, Mohammad
    Ebtekar, Fariba
    Gheshlagh, Reza Ghanei
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 589 - 599